Prothena Q3 2022 net loss $45.8M vs income $109.2M y/y; cash $497M; cuts FY22 net cash burn guidance to $108-120M

PROTHENA CORP PUBLIC LTD CO

2022-Q3 EPS reported -$2.63 revenue$3,982,000

Net loss $45.8M ($0.97 per share) vs net income $109.2M ($2.13 diluted EPS) in Q3 2021.
Total revenue $1.5M vs $139.2M y/y, primarily due to prior year BMS and Novo Nordisk milestones.
Cash and restricted cash $497.0M; no debt; shares outstanding ~48.4M as of Oct 26.
Updated FY2022 net cash burn guidance $108-120M (down from $120-132M); year-end cash ~$522M.
R&D expenses $39.9M in Q3 2022 vs $18.0M y/y, driven by manufacturing and clinical costs.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PROTHENA CORP PUBLIC LTD CO reported third quarter ended September 30, 2022 results: revenue $1.5 million, net income net loss of $45.8 million, EPS $0.97.

Period: third quarter ended September 30, 2022
Revenue: $1.5 million
Net income: net loss of $45.8 million
EPS: $0.97
Result: reported results

Exact text from the filing

For the third quarter and first nine months of 2022, Prothena reported a net loss of $45.8 million and $123.3 million, respectively, as compared to a net income o f $109.2 million and $100.2 million for the third quarter and first nine months of 2021, respectively. Net loss per share for the third quarter of 2022 and first nine months of 2022 was $0.97, and $2.63, respectively, a s compared to net income per share on a diluted basis of $2.13 and $2.12 f or the third quarter and first nine months of 2021, respectively. Prothena reported total revenue of $1.5 million and $4.0 million for the third quarter and first nine months of 2022, respectively, primarily from collaboration revenue from BMS.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

PROTHENA CORP PUBLIC LTD CO filing history →

Source: SEC EDGAR

accession 0001559053-22-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.